Chinese Journal of Stroke ›› 2021, Vol. 16 ›› Issue (02): 124-129.DOI: 10.3969/j.issn.1673-5765.2021.02.003
Previous Articles Next Articles
Received:
2020-10-08
Online:
2021-02-20
Published:
2021-02-20
杨启舟,付睿,王莉莉
通讯作者:
付睿 furui20080808@sina.com
YANG Qi-Zhou, FU Rui, WANG Li-li. Pathogenesis of Cancer-Associated Ischemic Stroke[J]. Chinese Journal of Stroke, 2021, 16(02): 124-129.
杨启舟,付睿,王莉莉. 肿瘤相关脑梗死发病机制的研究进展[J]. 中国卒中杂志, 2021, 16(02): 124-129.
[1] YOUNG B O,MYOUNG S J,GYEONG K S,et al.Ischemic stroke and cancer:stroke severely impactscancer patients,while cancer increases the numberof strokes[J]. J Clin Neurol,2011,7(2):53-59.[2] ZÖLLER B,JI J,SUNDQUIST J,et al. Risk ofhaemorrhagic and ischaemic stroke in patientswith cancer:a nationwide follow-up study fromSweden[J]. Eur J Cancer,2012,48(12):1875-1883.[3] BUDINCEVIC H,PIRŠIC A,BOHM T,et al.Carotid body tumor as a cause of stroke[J]. InternMed,2016,55(3):295-298.[4] BARGHOUTHI T,GIUGLIANO A,KIMSHAPIROJ W L,et al. Pearls & Oy-sters:Ⅳ andmechanical thrombolysis for ischemic strokesecondary to cardiac myxoma[J]. Neurology,2019,93(22):975-977.[5] ZHENG Z,GUO G J,XU L,et al. Left atrialmyxoma with versus without cerebral embolism:length of symptoms,morphologic characteristics,and outcomes[J]. Texas Heart Inst J,2014,41(6):592-595.[6] STERGIOPOULOS K,VASU S,BILFINGER T,etal. Embolic stroke in a patient with metastatic renalcell cancer[J]. Hellenic J Cardiol,2011,52(3):256-258.[7] DIMITROVI? A,BREITENFELD T,SUPANC V,et al. Stroke caused by lung cancer invading the leftatrium[J/OL]. J Stroke Cerebrovasc Dis,2016,25(5):e66-e68[2020-10-08]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.12.043.[8] COLLINS R C,AL-MONDHIRY H,CHERNIKN L,et al. Neurologic manifestations ofintravascular coagulation in patients with cancer. Aclinicopathologic analysis of 12 cases[J]. Neurology,1975,25(9):795-806.[9] KIM S G,HONG J M,KIM H Y,et al. Ischemicstroke in cancer patients with and withoutconventional mechanisms:a multicenter study inKorea[J]. Stroke,2010,41(4):798-801.[10] KARLI?SKA A G,GROMADZKA G,KARLI?SKI M A,et al. The activity of malignancymay determine stroke pattern in cancer patients[J]. JStroke Cerebrovasc Dis,2015,24(4):778-783.[11] SCHWARZBACH C J,SCHAEFER A,EBERT A,et al. Stroke and cancer:the importance of cancerassociatedhypercoagulation as a possible strokeetiology[J]. Stroke,2012,43(11):3029-3034.[12] DEARBORN J L,URRUTIA V C,ZEILER S R.Stroke and cancer- a complicated relationship[J]. JNeurol Transl Neurosci,2014,2(1):1039. [13] SELVIK H A,THOMASSEN L,LOGALLO N,etal. Prior cancer in patients with ischemic stroke:theBergen NORSTROKE study[J]. J Stroke CerebrovascDis,2014,23(5):919-925.[14] LEE A Y. Cancer and thromboembolic disease:pathogenic mechanisms[J]. Cancer Treat Rev,2002,28(3):137-140.[15] FRANCO A T,CORKEN A,WARE J. Plateletsat the interface of thrombosis,inflammation,andcancer[J]. Blood,2015,126(5):582-588.[16] PENG Z K,SHU B Y,ZHANG Y R,et al.Endothelial response to pathophysiological stress[J/OL]. Arterioscler Thromb Vasc Biol,2019,39(11):e233-e243[2020-10-08]. https://doi.org/10.1161/atvbaha.119.312580.[17] NAVI B B,REINER A S,KAMEL H,et al.Association between incident cancer and subsequentstroke[J]. Ann Neurol,2015,77(2):291-300.[18] LEFKOVITZ N W,ROESSMANN U,KORI S H.Major cerebral infarction from tumor embolus[J].Stroke,1986,17(3):555-557.[19] OJEDA V J,FROST F,MASTAGLIA F L. Nonbacterialthrombotic endocarditis associated withmalignant disease:a clinicopathological study of 16cases[J]. Med J Aust,1985,142(12):629-631.[20] GLASS J P. The diagnosis and treatment of strokein a patient with cancer:nonbacterial thromboticendocarditis(NBTE):a case report and review[J].Clin Neurol Neurosurg,1993,95(4):315-318.[21] ROYTER V,COHEN S N. Recurrent embolicstrokes and cardiac valvular disease in a patient withnon-small cell adenocarcinoma of lung[J]. J NeurolSci,2006,241(1/2):99-101.[22] STEINER I. Nonbacterial thrombotic endocarditis-astudy of 171 case reports[J]. Cesk Patol,1993,29(2):58-60.[23] EDOUTE Y,HAIM N,RINKEVICH D,et al.Cardiac valvular vegetations in cancer patients:aprospective echocardiographic study of 200patients[J]. Am J Med,1997,102(3):252-258.[24] LIU J,FRISHMAN W H. Nonbacterial thromboticendocarditis:pathogenesis,diagnosis,andmanagement[J]. Cardiol Rev,2016,24(5):244-247.[25] ZEMBOWER T R. Epidemiology of infections incancer patients[J/OL]. Cancer Treat Res,2014,161:43-89[2020-10-08]. https://doi.org/10.1007/978-3-319-04220-6_2.[26] BOS M M E M,SMEETS L S,DUMAY I,et al.Bloodstream infections in patients with or withoutcancer in a large community hospital[J]. Infection,2013,41(5):949-958.[27] FRIEDL P,ALEXANDER S. Cancer invasion andthe microenvironment:plasticity and reciprocity[J].Cell,2011,147(5):992-1009.[28] ELKIND M S V. Inflammatory mechanisms ofstroke[J/OL]. Stroke,2010,41(10 Suppl):S3-8[2020-10-08]. https://doi.org/10.1161/strokeaha.110.594945.[29] FUGATE J E,LYONS J L,THAKUR K T,et al.Infectious causes of stroke[J]. Lancet Infect Dis,2014,14(9):869-880.[30] SAYNAK M,COSAR-ALAS R,YURUTCALOGLUV,et al. Chemotherapy andcerebrovascular disease[J]. J BUON,2008,13(1):31-36.[31] WALL J G,WEISS R B,NORTON L,et al. Arterialthrombosis associated with adjuvant chemotherapyfor breast carcinoma:a cancer and leukemia group Bstudy[J]. Am J Med,1989,87(89):501-504.[32] DE CELIS E,ALONSO DE LECIÑANA M,RODRÍGUEZ-PARDO J,et al. Increased risk ofischemic stroke in multiple myeloma associated withlenalidomide treatment:a case report and review ofthe literature[J]. Clin Neuropharmacol,2018,41(6):232-235.[33] ROBINSON D,GARMO H,LINDAHL B,et al.Ischemic heart disease and stroke before and duringendocrine treatment for prostate cancer in PCBaSeSweden[J]. Int J Cancer,2012,130(2):478-487.[34] MOSCA L,GRADY D,BARRETT-CONNORE,et al. Effect of raloxifene on stroke and venousthromboembolism according to subgroups inpostmenopausal women at increased risk of coronaryheart disease[J]. Stroke,2009,40(1):147-155.[35] ESTEVA F J,HORTOBAGYI G N. Comparativeassessment of lipid effects of endocrine therapyfor breast cancer:implications for cardiovasculardisease prevention in postmenopausal women[J].Breast,2006,15(3):301-312.[36] YANG T L,WU T C,HUANG C C,et al.Association of tamoxifen use and reducedcardiovascular events among Asian females withbreast cancer[J]. Circ J,2014,78(1):135-140.[37] AZOULAY L,YIN H,BENAYOUN S,et al.Androgen-deprivation therapy and the risk of strokein patients with prostate cancer[J]. Eur Urol,2011,60(6):1244-1250.[38] JESPERSEN C G,NØRGAARD M,BORREM. Androgen-deprivation therapy in treatment ofprostate cancer and risk of myocardial infarction andstroke:a nationwide Danish population-based cohortstudy[J]. Eur Urol,2014,65(4):704-709. [39] LIU R L,ZHOU J T,XIA S,et al. Androgendeprivation therapy and the risk of stroke in patientswith prostate cancer:an updated systematic reviewand meta-analysis[J]. Urol Int,2020,104(3/4):214-221.[40] CHUNG S D,CHEN Y K,WU F J,et al. Hormonetherapy for prostate cancer and the risk of stroke:a5-year follow-up study[J]. BJU Int,2012,109(7):1001-1005.[41] TAE B S,JEON B J,CHOI H,et al. Is androgendeprivation therapy associated with cerebralinfarction in patients with prostate cancer? A Koreannationwide population-based propensity scorematching study[J]. Cancer Med,2019,8(9):4475-4483.[42] SCOTT A S,PARR L A,JOHNSTONE P A.Risk of cerebrovascular events after neck andsupraclavicular radiotherapy:a systematic review[J].Radiother Oncol,2009,90(2):163-165.[43] STEWART F A,HOVING S,RUSSELL N S,etal. Vascular damage as an underlying mechanismof cardiac and cerebral toxicity in irradiated cancerpatients[J]. Radiat Res,2010,174(6):865-869.[44] DORRESTEIJN L D,KAPPELLE A C,BOOGERDW,et al. Increased risk of ischemic stroke afterradiotherapy on the neck in patients younger than 60years[J]. J Clin Oncol,2002,20(1):282-288.[45] HUNG S K,LEE M S,CHIOU W Y,et al. Highincidence of ischemic stroke occurrence in irradiatedlung cancer patients:a population-based surgicalcohort study[J/OL]. PLoS One,2014,9(4):e94377[2020-10-08]. https://doi.org/10.1371/journal.pone.0094377.[46] MUELLER S,FULLERTON H J,STRATTON K,et al. Radiation,atherosclerotic risk factors,andstroke risk in survivors of pediatric cancer:a reportfrom the childhood cancer survivor study[J]. Int JRadiat Oncol Biol Phys,2013,86(4):649-655.[47] 李真,武丹娜. 恶性肿瘤合并缺血性卒中的研究进展[J]. 临床荟萃,2016,31(7):809-812.[48] YAMAMOTO T,SUZUKI H,NAGATO K,et al.Is left upper lobectomy for lung cancer a risk factorfor cerebral infarction?[J]. Surg Today,2016,46(7):780-784.[49] KAMIYA-MATSUOKA C,CACHIA D,YUSTKATZS,et al. Ischemic stroke in patients withgliomas at the University of Texas-M. D. AndersonCancer Center[J]. J Neurooncol,2015,125(1):143-148. |
[1] | WU Yuqian, ZHANG Yumei, FAN Xiaowei, WANG Anxin, PANG Wenbin. The Efficacy of Kinesthetic Motor Imagery Therapy for Hand Function Rehabilitation of Stroke Patients [J]. Chinese Journal of Stroke, 2022, 17(12): 1366-1371. |
[2] | YI Luo, ZHOU Hongyu, QIU Xin, LI Zixiao, WANG Yongjun. DNA Methylation Changes in Atherosclerotic Diseases [J]. Chinese Journal of Stroke, 2022, 17(11): 1163-1170. |
[3] | WANG Yubo, LI Zixiao, WANG Yongjun. Progress of the Relationship between Epigenetics and Oxidative Stress after Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1171-1177. |
[4] | CUI Lingyun, QIU Xin, ZHOU Hongyu, LI Zixiao, WANG Yongjun. Progress of the Relationship between DNA Methylation and Type 2 Diabetes [J]. Chinese Journal of Stroke, 2022, 17(11): 1183-1188. |
[5] | LIU Guangliang, HAN Kaiyue, SU Wenlong, ZHANG Hao. Effects of Aerobic Cycling Training Intensity on Motor and Cardiopulmonary Fitness in Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1203-1208. |
[6] | XU Yingxin, ZHANG Shuang, ZHOU Xiaomei, YUAN Jinglin, ZHAO Liuzhuang, YANG Haihua. Correlation of Non-Stenotic Carotid Plaque with Anterior Circulation Embolic Stroke of Undetermined Source [J]. Chinese Journal of Stroke, 2022, 17(11): 1233-1237. |
[7] | CHENG Shi, LI Jing, GUO Junping, HU Aixiang, YU Xinwei, HAN Wei, LIANG Ying, ZHANG Yuewei, JI Ruijun. Clinical Characteristics and Risk Factors of Infection in Patients with Acute Stroke during Hospitalization [J]. Chinese Journal of Stroke, 2022, 17(10): 1065-1070. |
[8] | XIANG Wei, XU Luyao, ZHANG Manman, WEI Hongchun, LIANG Zhigang. The Frequency and Influencing Factors of Asymmetrical Prominent Veins Sign on Susceptibility-Weighted Imaging in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1097-1102. |
[9] | ZHAO Yongrui, LIU Zhanhui. Progress of Diffusion Tensor Imaging in Evaluating Motor Function Prognosis of Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1114-1119. |
[10] | ZHANG Boyu, GUO Yucheng, CUI Yuxia, LI Yingli, LYU Yumei. Seeking Medical Services Decision-Making Status and Relevant Influencing Factors in Patients with Acute Ischemic Stroke: A Review [J]. Chinese Journal of Stroke, 2022, 17(10): 1127-1132. |
[11] | WU Tingting, LIU Yafei, YAN Shixi, WU Yiping, ZHANG Zhongbo, ZAHNG Hanfei, FANG Pinping. Application of “Internet Plus” in Emergency Care of Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1133-1138. |
[12] | ZHANG Yige, ZHANG Wan, ZHANG Luyang, WANG Xin, DING Lan, WANG Yuying, PEI Lulu, FANG Hui, XU Yuming, SONG Bo. Association of Artery Occlusion and Recurrent Ischemic Stroke Related with Cerebral Artery Dissection [J]. Chinese Journal of Stroke, 2022, 17(09): 932-936. |
[13] | LYU Wei, WANG Anxin, TIAN Xue, ZHANG Xiaoli, XU Yuyuan, MENG Xia. Effect of Xinxuening Capsule on Short-term Functional Outcome in Patients with Ischemic Stroke and High Homocysteine Level [J]. Chinese Journal of Stroke, 2022, 17(09): 972-976. |
[14] | ZHANG Xinmiao, PAN Yuesong, XIANG Xianglong, WANG Yongjun, MENG Xia. Early Clinical Pathway Intervention to Improve the Key Performance Indicators of Medical Care for Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(09): 977-984. |
[15] | XU Luyao, CHEN Xiaodi, LIANG Zhigang. Advances in Imaging Evaluation of Post-stroke Aphasia [J]. Chinese Journal of Stroke, 2022, 17(09): 1017-1021. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||